Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
JNJ · against 5 other Healthcare companies of similar size
Ranked #1 of 6 · scores higher than 100% of peers · safety percentile 38
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)1 peers with a safety percentile of 30–39, including JNJ · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | JNJ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 5 reported | 0.58× | 0.91× | 100% | 33% | |
| BetaLower is better · 6 reported | 0.23 | 0.29 | 60% | 33% | |
| Current ratioHigher is better · 6 reported | 1.09× | 1.16× | 40% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 622.8B USD | 38 | 59 | |
| 2 | 293.8B CHF (≈$337.9B) | 26 | 61 | |
| 3 | 337.5B USD | 25 | 48 | |
| 4 | 352.3B USD | 19 | 37 | |
| 5 | 1.06T USD | 13 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score